The studies for Mega Bac include:  Activity has been demonstrated in laboratory assays at low concentrations against a broad range of relevant bacteria, protozoa, fungi and viruses, including: S.aureus (golden staph), E. Coli, P. aeruginosa, C. albicans (thrush), S. epidermidis, K. pneumonia, Legionella, Salmonella, Listeria, Vancomycin, resistant Enterococcus faecum (VRE) rotavirus, herpes simplex, hepatitis A and B, influenza and para tuberculosis. - Toxicity studies have been conducted using laboratory rats and found that a bolus oral ingestion of MegaBac (10% concentration) was not toxic. A longer study is underway.
- A skin toxicity study on rodents (guinea pigs) as required by regulatory authorities for new pharmaceuticals to be used in human trials found no adverse reactions at 25% concentration suggesting that human exposure at 5% (as in NeuMedix Pain Relief Oil) is safe.
- Using recognised testing procedures, MegaBac demonstrated effectiveness against human influenza Type A in embryonic hens eggs, a standard testing model, with no impact on the embryo.
- Following testing procedures by the CSIRO MegaBac deactivated the H5N1 strain of influenza virus, avian or bird flu, in embryonic chicken eggs.
The studies for M.A.C. include: - Completed in vitro studies of effectiveness against Herpes Simplex Virus 2 (AMS Labs, Sydney) and a 6 patient trial (clinician Sydney).
- First results on dengue fever (University of Indonesia) have shown Log 5 reductions against this virus for which there is no known cure.
- Complete inhibition of Mycobacterium tuberculosis (TB) was shown in laboratory studies of MegaBac. Multi Drug Resistant TB studies are underway in Indonesia. Results shown by two patients are reduced lung mass, less sputum production and weight gain (average 4 kilos). A full clinical TB trial is about to start in Indonesia.
These studies were conducted by independent, external laboratories using approved testing procedures. They are highly encouraging suggesting that the product may be effective against bird flu and tuberculosis, amongst other pathogenic bacteria and viruses, and is safe for application to open wounds and for oral ingestion. Results on MAC show it to be 20 times more effective than Mega Bac and 200 times more powerful than base Melaleuca oil: 
|
